INTRODUCTION
It has been established that before exerting its biological effects vitamin D is metabolized to more polar, biologically active metabolites (1) . The first of these, 25-hydroxycholecalciferol (25[OH] Ds)1 was shown to be produced by a hepatic hydroxylation system (2) . The second, which is produced in the kidney (3) , has been identified as 1,25-dihydroxycholecalciferol (1, 25 [OH]2D3) (4) and shown to be the metabolite responsible for the increase in intestinal calcium transport observed after vitamin D administration to D-deficient animals (4, 6) .
Boyle, Gray, and DeLuca have shown that when the plasma calcium concentration in D-deficient rats is low, the rate of conversion of 25(OH)D3 to 1,25(OH)2Da in vivo (as measured by the amount of 1,25[0H]2D3 isolated from the intestinal mucosa) is increased, but the conversion to 21,25 (OH) Ds was decreased (6) . Dr 
METHODS
Isolated chick renal tubules were prepared by a technique previously described employing enzymatic digestion of minced renal tissue with hyaluronidase and collagenase (7, 9) . After preparation in a modified Krebs-Ringer bicarbonate buffer, the tubules were washed and diluted to a concentration of 10 mg tubule protein per ml. 1-ml portions from this prepaThe Journal of Clinical Investigation Volume 51 September 1972 ration were placed in each incubator flask to which was added the appropriate hormone or carrier. The reaction was started with the addition of 0.3 Asg of [26,27-3H2] 25-hydroxyvitamin D3 (New England Nuclear Corp., Boston, Mass., specific activity 315 mCi/mmole). Incubations were carried out in siliconized 25-ml flasks for 15 or 30 min in KRB containing 2.0%o bovine serum albumin, 1.0 mm CaCl2 2 mm Na pyruvate, and 2 mm glucose at pH 7.4 and 370C with 95% 0-5% C02 as the gas phase. The reaction was stopped by the addition of 5 ml of ice-cold 95%o ethanol. The cells were collected by centrifugation, the supernate decanted, and the cell pellet then extracted three times with 95%o ethanol, two times with CHCls: ethanol (2: 1), and once with diethyl ether. The combined extracts were taken to dryness under N2, taken up in a small volume of ethyl acetate, and applied to a thin layer of Silica Gel G (0.5 mm in thickness; Brinkmann Instruments, Inc., Westbury, N. Y.), before development with 100% ethyl acetate in complete darkness for 40 min. Sixteen 1 cm strips of the Silica Gel were scraped from the plate into a scintillation vial containing 0.3 ml H20, and 10 ml of a counting solution consisting of the toluene solution of PPO-POPOP mixed with methyl cellusolve in the ratio of 100: 60 (v/v). Final recovery of radioactivity added to the incubation was 75-80%; counting efficiency was approximately 20%. All counting was performed in a Packard model 3320 scintillation counter (Packard Instrument Co., Inc., Downers Grove, Ill.). All samples were corrected for quenching by the channels ratio procedure. Identification of 25-hydroxy-(R, = 0.63) and 1,25-dihydroxycholecalciferol (R, = 0.40) was verified by previously described methods, which included counter-current distribution, Sephadex LH-20 (Pharmacia Fine Chemicals, Inc., Piscataway, N. J.) chromatography, sensitivity to periodate, and examination of the biological activity of the isolated product (7) . The data were first expressed in disintegrations per minute, and then converted to nanograms of 1,25(OH)2Ds produced. Protein was deter- Table I . The addition of 0.5 ng PTH per ml consistently caused a slight decrease (P < 0.1 ) in the amount of 1,25(OH)2D3 produced. A concentration of 1.0 ng/ml had no effect, but doses between 5.0 and 50.0 ng/ml stimulated 1,25(OH)2D3 production. A 10-fold higher concentration (500 ng/ml) had no effect upon 1,25(OH)2D3 production.
The other known effect of PTH upon renal metabolism is that of activating adenyl cyclase (12) . Because of this fact, the effect of exogenous cyclic AMP upon 1,25-(OH)2D3 production was examined. The addition of 10' to 10' M cAMP caused a significant increase in Hormonal Control of 1,25 (OH).Ds Production 1,25(OH)2D3 production, but 10' M or greater cAMP had no effect (Table I) . Thus, in the case of both PTH and exogenous cAMP, there was biphasic response with stimulation of 1,25 (OH)2D3 production at low concentrations, but no stimulation at very high concentrations. In contrast to PTH and cAMP, CT inhibited 1,25-(OH )2D3 production ( Table I ). The maximal effect was observed at a CT concentration of 5.0-10 ng/ml. 10-to 100-fold higher concentrations were less effective but still produced a significant inhibition. Also, when optimal doses of both PTH (10 ng/ml) and CT (5 ng/ml) were added simultaneously (Table I) , CT did not block the effect of PTH. However, when the concentration of PTH was 1.0 ng/ml, CT caused a normal inhibition of 1,25(OH)2D3 synthesis. These results mean that at high PTH (75.0 ng/ml) and normal or low CT (< 5.0 ng/ml) concentrations, the effect of PTH is seen, but at low PTH (< 1.0 ng/ml) and normal CT (5.0 ng/ml) concentrations, the effect of CT is seen. 
